The association between antidepressant use and depression eight years later: A national cohort study

Journal of Psychiatric Research

Volumn 45, Issue 8, 2011, Pages 1012-1018

  Colman, Ian ^a   Zeng, Yiye ^a   Ataullahjan, Anushka ^a   Senthilselvan, Ambikaipakan ^a   Patten, Scott B ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antidepressive agents; Depressive disorder; Longitudinal studies; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; SOCIAL SUPPORT; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CANADA; CONFIDENCE INTERVALS; DEPRESSION; HUMANS; LONGITUDINAL STUDIES; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES;

EID: 79960580984     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.02.001     Document Type: Article

References (44)

1. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington.
2. Andrews G., Issakidis C., Carter G. Shortfall in mental health service utilisation. The British Journal of Psychiatry 2001, 179:417-425.
3. Barbui C., Hotopf M. Forty years of antidepressant drug trials. Acta Psychiatrica Scandinavica 2001, 104:92-95.
4. Barbui C., Esposito E., Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Canadian Medical Association Journal 2009, 180:291-297.
5. Bockting C.L., ten Doesschate M.C., Spijker J., Spinhoven P., Koeter M.W., Schene A.H. Continuation and maintenance use of antidepressants in recurrent depression. Psychotherapy and Psychosomatics 2008, 77:17-26.
6. Bockting C.L., Spinhoven P., Wouters L.F., Koeter M.W., Schene A.H. Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study. Journal of Clinical Psychiatry 2009, 70:1621-1628.
7. Burns T., Eichenberger A., Eich D., Ajdacic-Gross V., Angst J., Rossler W. Which individuals with affective symptoms seek help? Results from the Zurich epidemiological study. Acta Psychiatrica Scandinavica 2003, 108:419-426.
8. Colman I., Wadsworth M.E., Croudace T.J., Jones P.B. Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort. The British Journal of Psychiatry 2006, 189:156-160.
9. Colman I., Croudace T.J., Wadsworth M.E., Kuh D., Jones P.B. Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics. The British Journal of Psychiatry 2008, 193:327-331.
10. Colman I., Croudace T.J., Wadsworth M.E.J., Jones P.B. Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort. Journal of Affective Disorders 2008, 110:234-240.
11. Conniffe D., Gash V., O'Connell P.J. Evaluating state programmes: "natural experiments" and propensity scores. The Economic and Social Review 2000, 31:283-308.
12. Cornwall P.L., Scott J. Partial remission in depressive disorders. Acta Psychiatrica Scandinavica 1997, 95:265-271.
13. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 1998, 17:2265-2281.
14. DeRubeis R.J., Siegle G.J., Hollon S.D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nature Reviews. Neuroscience 2008, 9:788-796.
15. Fava G.A., Ruini C., Rafanelli C., Finos L., Conti S., Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. The American Journal of Psychiatry 2004, 161:1872-1876.
16. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. The Journal of American Medical Association 2010, 303:47-53.
17. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361:653-661.
18. Helgason T., Tomasson H., Zoega T. Antidepressants and public health in Iceland. Time series analysis of national data. The British Journal of Psychiatry 2004, 184:157-162.
19. Hollon S.D., DeRubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P., et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry 2005, 62:417-422.
20. Kennedy N., Abbott R., Paykel E.S. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychologie Medicale 2003, 33:827-838.
21. Kessler R.C., Andrews G., Mroczek D., Ustun B., Wittchen H.-U. The world health organization composite international diagnostic interview short-form (CIDI-SF). International Journal of Methods in Psychiatric Research 1998, 7:171-185.
22. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.L., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychologie Medicale 2002, 32:959-976.
23. Kisely S., Linden M., Bellantuono C., Simon G., Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychologie Medicale 2000, 30:1217-1225.
24. Kwon A., Bungay K.M., Pei Y., Rogers W.H., Wilson I.B., Zhou Q., et al. Antidepressant use: concordance between self-report and claims records. Medical Care 2003, 41:368-374.
25. Leon A.C., Solomon D.A., Mueller T.I., Endicott J., Rice J.P., Maser J.D., et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. The American Journal of Psychiatry 2003, 160:727-733.
26. Mead N., Lester H., Chew-Graham C., Gask L., Bower P. Effects of befriending on depressive symptoms and distress: systematic review and meta-analysis. The British Journal of Psychiatry 2010, 196:96-101.
27. Middleton N., Gunnell D., Whitley E., Dorling D., Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. Journal of Public Health and Medicine 2001, 23:262-267.
28. Mojtabai R., Olfson M., Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Archives of General Psychiatry 2002, 59:77-84.
29. Moret C., Isaac M., Briley M. Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology 2009, 23:967-974.
30. Mueller T.I., Leon A.C., Keller M.B., Solomon D.A., Endicott J., Coryell W., et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. The American Journal of Psychiatry 1999, 156:1000-1006.
31. Ormel J., Oldehinkel T., Brilman E., vanden Brink W., vanden Brink W. Outcome of depression and anxiety in primary care. A three-wave 3 1/2-year study of psychopathology and disability. Archives of General Psychiatry 1993, 50:759-766.
32. Patten S.B., Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Canadian Journal of Psychiatry 2004, 49:303-309.
33. Pintor L., Gasto C., Navarro V., Torres X., Fananas L. Relapse of major depression after complete and partial remission during a 2-year follow-up. Journal of Affective Disorders 2003, 73:237-244.
34. Rao J.N.K., Wu C.F.J. Resampling inference with complex survey data. Journal of the American Statistical Association 1988, 83:231-241.
35. Rosenbaum P., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
36. Rouillon F. Long term therapy of generalized anxiety disorder. European Psychiatry 2004, 19:96-101.
37. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Annals of Internal Medicine 1997, 127:757-763.
38. Spijker J., Bijl R.V., de Graaf R., Nolen W.A. Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). Acta Psychiatrica Scandinavica 2001, 104:19-24.
39. Spijker J., de Graaf R., Bijl R.V., Beekman A.T., Ormel J., Nolen W.A. Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). Journal of Affective Disorders 2004, 81:231-240.
40. Starkes J.M., Poulin C.C., Kisely S.R. Unmet need for the treatment of depression in Atlantic Canada. Canadian Journal of Psychiatry 2005, 50:580-590.
41. Statistics Canada National population health survey cycle 3 (1998-1999) 1999, Public Use Microdata Files Documentation, Ottawa.
42. Statistics Canada National population health survey cycle 7 (2006-2007) 2007, Public Use Microdata Files Documentation, Ottawa.
43. Teasdale J.D., Scott J., Moore R.G., Hayhurst H., Pope M., Paykel E.S. How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. Journal of Consulting and Clinical Psychology 2001, 69:347-357.
44. Viinamaki H., Hintikka J., Tolmunen T., Honkalampi K., Haatainen K., Koivumaa-Honkanen H. Partial remission indicates poor functioning and a high level of psychiatric symptoms: a 3-phase 6-year follow-up study on major depression. Nordic Journal of Psychiatry 2008, 62:437-443.